Stanford University/Stanford Healthcare
Palo Alto, California, 94305, United States
NCT Number: NCT04624880
Hypnosis is an effective pain management tool for surgery that can reduce opioid use up to 40%. COMT single nucleotide polymorphisms (SNPs) can predict pain sensitivity and opioid use perioperatively, and may also be associated with hypnotizability or response to hypnotic analgesia. Analyzing COMT haplotypes from DNA extracted from saliva or blood using a giant magnetoresistive (GMR) nanotechnology platform may be faster, less expensive, and at least as accurate as pyrosequencing. This study aims to validate a multi-SNP point-of-care (POC) GMR assay for the rapid genotyping of SNPs predictive of COMT activity, and test the feasibility of using COMT activity as a biomarker for hypnotizability and/or response to hypnotic analgesia.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Palo Alto, California, 94305, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Giant magnetoresistive sensor analyzes genetic polymorphisms in patient samples.
Time frame: Through study completion, average of 2 years
We will test the hypothesis that the four COMT SNPs (rs4680, rs4818, rs4633, and rs6269) can be detected on the GMR platform with 99% accuracy when compared to pyrosequencing
Time frame: Through study completion, average of 2 years
Time frame: Through study completion, average of 2 years
Determine if there is a relationship between COMT diplotypes/haplotypes and pain or opioid use in a subgroup of patients who underwent hypnosis prior to knee replacement surgery vs. patients in the control group who were not hypnotized, during their inpatient admission postoperatively
Stanford University
Other
COMT Activity as a Biomarker for Hypnotizability and Hypnotic Analgesia Using a Multiplexed Precision Medicine Platform
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06498713
Agnosia, Nervous System Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT06217263
Agnosia, Chest Tubes
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07248384
Agnosia, Nervous System Diseases
Karachi, Sindh, Pakistan
View Trial DetailsNCT04343807
Agnosia, Anaesthesia
Karachi, Sindh, Pakistan
View Trial Details